Results 241 to 250 of about 104,742 (284)
Some of the next articles are maybe not open access.
Management of Malignant Pleural Effusions
Chest, 1993Malignant pleural effusions (MPEs) are a common complication of advanced malignancies, particularly lung and breast cancer. They are caused by a variety of mechanisms including tumor obstruction of lymphatic flow, spread of malignant cells via the systemic circulation, and tumor invasion of the pulmonary arterioles.
openaire +3 more sources
Treatment of malignant pleural effusions
Current Opinion in Pulmonary Medicine, 1999Malignant pleural effusions are common in cancer patients with advanced disease. These patients usually present with chest pain, cough, and progressive shortness of breath, all of which may cause significant impairment in quality of life. Therapeutic options include systemic treatment; thoracentesis; or, most commonly, tube drainage and sclerotherapy ...
Edward F. Patz, Jeremy J. Erasmus
openaire +3 more sources
Treatment of Malignant Pleural Effusion
Chest, 1985Two hundred consecutive patients with malignant pleural effusion were reviewed. The pathologic etiology of malignant pleurisy was: primary lung cancer in 123 cases; five, mesothelioma; and 72 cases secondary to metastatic tumors. Adenocarcinoma of the lung and mammary cancer were the most frequent tumors causing malignant pleural effusion.
Yoshiki Takeuchi +4 more
openaire +2 more sources
Sonography of malignant pleural effusion
European Radiology, 1997Two hundred and ten patients with exudative pleural effusion were studied by ultrasound for sonographic signs of pleural carcinomatosis. Images were evaluated for echoes within the fluid, septations, sheet-like or nodular pleural masses, and associated lesions of the lung. Our results showed that sonographic findings of echogenic or septated fluid were
Christian Görg +2 more
openaire +3 more sources
2006
Malignant pleural effusion, a common complication of advanced malignancy, is associated with significant morbidity and mortality. The symptoms of MPE (dyspnea, cough, pleuritic pain) can be debilitating and can result in prolonged hospitalization at a considerable cost.
Roberto V. Barresi, Keith W. Millikan
openaire +2 more sources
Malignant pleural effusion, a common complication of advanced malignancy, is associated with significant morbidity and mortality. The symptoms of MPE (dyspnea, cough, pleuritic pain) can be debilitating and can result in prolonged hospitalization at a considerable cost.
Roberto V. Barresi, Keith W. Millikan
openaire +2 more sources
Annali italiani di chirurgia, 2007
Malignant pleural effusion is a frequent condition with important prognostic repercussions on duration and quality of life. The neoplasms that more frequently determine pleural effusion are lung and breast cancer and pleural mesothelioma. Lymphomas, tumours of the genitourinary tract and gastrointestinal tract as a group account for a further 25 ...
Cusumano G. +10 more
openaire +2 more sources
Malignant pleural effusion is a frequent condition with important prognostic repercussions on duration and quality of life. The neoplasms that more frequently determine pleural effusion are lung and breast cancer and pleural mesothelioma. Lymphomas, tumours of the genitourinary tract and gastrointestinal tract as a group account for a further 25 ...
Cusumano G. +10 more
openaire +2 more sources
Seminars in oncology, 1991
Malignancy is the most common cause of exudative pleural effusion in patients over the age of 60 years. Control of the effusion significantly reduces morbidity and improves quality of life. Tube thoracostomy with subsequent chemical pleurodesis is the treatment of choice for patients with tumors that are relatively insensitive to systemic chemotherapy.
openaire +3 more sources
Malignancy is the most common cause of exudative pleural effusion in patients over the age of 60 years. Control of the effusion significantly reduces morbidity and improves quality of life. Tube thoracostomy with subsequent chemical pleurodesis is the treatment of choice for patients with tumors that are relatively insensitive to systemic chemotherapy.
openaire +3 more sources
The treatment of malignant pleural effusions
Cancer, 1974This report reviews a 5-year experience in the treatment of malignant pleural effusion with particular emphasis on the use of closed-tube thoracostomy drainage with nitrogen mustard instillation. Of the 133 patients treated at the Barnes Hospital for malignant pleural effusion between January 1 1964 and December 31 1968 bilateral effusions were ...
Gordon W. Philpott +2 more
openaire +2 more sources
Phenotyping malignant pleural effusions
Current Opinion in Pulmonary Medicine, 2016Patients with malignant pleural effusions (MPEs) are heterogenous in their disease course, symptom severity, responses to cancer therapies, fluid recurrence rates, and thus need for definitive fluid control measures. To tailor the most appropriate treatment for individual patients, clinicians need to 'phenotype' the patients and predict their clinical ...
Macy Mei Sze Lui +2 more
openaire +3 more sources
Malignant Pleural Effusion: Presentation, Diagnosis, and Management.
American Journal of Medicine, 2022S. Gayen
semanticscholar +1 more source